|
1
|
Colman H, Raizer JJ, Walbert T, Plotkin SR, Chamberlain MC, Wong ET, Puduvalli VK, Reardon DA, Iwamoto FM, Mrugala MM, Johnson B, Sonty K, Karlin DA, Pelayo M, Hutchinson M, Hsu H. Phase 1b/2 study of pexidartinib (PEX) in combination with radiation therapy (XRT) and temozolomide (TMZ) in newly diagnosed glioblastoma. J Clin Oncol 2018. [DOI: 10.1200/jco.2018.36.15_suppl.2015] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
| | - Jeffrey J. Raizer
- Robert H. Lurie Cancer Center of Northwestern University, Chicago, IL
| | | | | | | | - Eric T. Wong
- Beth Israel Deaconess Medical Center, Boston, MA
| | | | - David A. Reardon
- Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA
| | | | | | - Brett Johnson
- Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
| | | | | | | | | | | |
Collapse
|
|
2
|
Cohen A, Sonty K, Jensen R, Shrieve D, Salzman K, Johnson B, Thomas M, Moss W, Behunin A, Prystas E, Colman H. ACTR-84. D-TERMINED: A PHASE 1 TRIAL IN NEWLY DIAGNOSED HIGH GRADE GLIOMA WITH TEMOZOLOMIDE, RADIATION, AND MINOCYCLINE FOLLOWED BY ADJUVANT MINOCYCLINE/TEMOZOLOMIDE. Neuro Oncol 2017. [DOI: 10.1093/neuonc/nox168.070] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
|
3
|
Colman H, Raizer J, Walbert T, Plotkin S, Chamberlain M, Wong E, Puduvalli V, Reardon D, Iwamoto F, Johnson B, Sonty K, Welbourn B, Karlin D, Pelayo M, Hutchinson M, Hsu H. ACTR-20. INITIAL RESULTS OF PLX108-08: AN OPEN LABEL PHASE 1B/2 STUDY OF ORALLY ADMINISTERED PEXIDARTINIB (PLX3397) IN COMBINATION WITH RADIATION THERAPY AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA. Neuro Oncol 2016. [DOI: 10.1093/neuonc/now212.019] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|